Despite significant declines in mortality and DALYs for heart, lung, and blood diseases in the U.S. from 1990 to 2016, the U.S. continues to have a higher disease burden compared to peer high-income countries, highlighting a widening health disadvantage.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Coles et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: